Navigation Links
GlycoVaxyn AG announces Addition of Gerd Zettlmeissl, as Chairman of the Board of Directors
Date:3/6/2013

ny," said Michel Greco , Chairman of the Board of Directors of GlycoVaxyn. "After having chaired the Board for more than seven years, I will work very closely with Gerd to ensure a smooth transition."

Philippe Dro , Chief Executive Officer of GlycoVaxyn added, "The changes to the Board and the appointment of Gerd will contribute to support GlycoVaxyn's strategic ambitions to become a major player in the development of a new generation of vaccines, particularly following our recently signed collaborations with GlaxoSmithKline Biologicals and Janssen Pharmaceuticals. We know Gerd very well and share with him a common passion for the development of innovative vaccines. After several years of close collaboration with Michel on this exciting project over the years, I would like to sincerely thank him, on behalf of the whole team, for his strong commitment and support."

About GlycoVaxyn AGGlycoVaxyn is a privately-funded company developing a portfolio of novel bio-conjugate vaccines against common severe bacterial infections produced with its unique, proprietary in vivo glycosylation platform. With this platform, the company can develop and produce immunogenic glycoprotein conjugates in a biological process that circumvents many of the challenges and uncertainties involved in currently/chemical used methods. In addition to the clinical stage Shigella vaccine, lead programs in preclinical stage are aimed at the prevention of hospital acquired Staphylococcus aureus infections. GlycoVaxyn recently entered collaborations with GlaxoSmithKline Biologicals and Janssen Pharmaceuticals. GlycoVaxyn is funded by a top-tier group of private investors including Sofinnova Partners, Index Ventures and Edmond de Rothschild Investment Partners.  For further information, visit www.glycovaxyn.com.Contacts:Robert FlammGlycoVaxyn AG

Russo Partne
'/>"/>

SOURCE GlycoVaxyn AG
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bayer CropScience Announces Seed Innovation at Pollinator Summit
2. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
3. lifeIMAGE Announces No-Cost Service for Hospitals to Give Patients Secure Access to Medical Imaging, Pledges Support for the Blue Button Initiative
4. Macrogen Corp. Announces the Inception of Macrogen Clinical Laboratory (MCL)
5. Quantum Cures Announces Breakthrough Approach for Researchers Seeking Cures for Orphan and Rare Diseases
6. Pittcon Announces the 2013 Pittsburgh Conference Memorial National College Grant Awardees
7. Research and Markets Announces Addition of the "Risk - Reward of Developing a Herceptin Biosimilar - A Thorough Assessment" Report to its Offering
8. Research & Markets Announces the Release of 'Analog Devices ADXL362 3-axis Micropower MEMS Accelerometer Reverse Costing Analysis'
9. Research & Markets Announces the Release of STMicroelectronics LSM303D 6-Axis Electronic Compass - Reverse Costing Analysis
10. Pamlab Announces Agreement for Sale of Business to Nestle Health Science
11. Elsevier Announces the Launch of a New Journal: Methods in Oceanography
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... to German life sciences entrepreneurs with a proven ... biotechnology (collectively, the "Optionee"), an option to license ... technology (the "Technology"), including AEZS-120, the most advanced ... to enter a Phase 1 clinical trial. This ...
(Date:7/28/2015)... Israel , July 28, 2015 /PRNewswire/ ... regenerative medicine company utilizing its proprietary plant-based rhCollagen ... Shomrat Shurtz has been appointed Senior Director of ...      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ) , ... experience in marketing, regulatory and business strategy. Prior ...
(Date:7/27/2015)... July 27, 2015  Amgen (NASDAQ: AMGN ) ... financial results on Thursday, July 30, 2015, after the ... be followed by a conference call with the investment ... from Amgen will be Robert A. Bradway , ... Amgen,s senior management team. Live audio of ...
(Date:7/27/2015)... , July 27, 2015 /PRNewswire/ - Quest PharmaTech Inc. ... developing and commercializing products for the treatment of cancer, ... announces that it has closed a $1,000,000 unit offering ... of 16,666,667 units of the Company at a price ... one common share and one common share purchase warrant.  ...
Breaking Biology Technology:Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3CollPlant Names Shomrat Shurtz Senior Director of Business Development 2Amgen Announces Webcast of 2015 Second Quarter Financial Results 2Quest PharmaTech Closes $1,000,000 Private Placement 2
... Germany, April 29 , - Strong ... - Annual General Meeting Passes Dividend of EUR0.40 ... of Gerresheimer AG today passed an unchanged,dividend of EUR0.40 per share ... The Company finished the financial year 2008 with record results.,Gerresheimer achieved ...
... Data for Ipilimumab to be Presented -PRINCETON, N.J., April ... announced today that the following clinical abstracts for ipilimumab ... an anti-PD-1 antibody for cancer treatment, have been selected ... Meeting of the American Society of Clinical Oncology, being ...
... effort to provide technology to reduce healthcare-associated infections, ... device company, has demonstrated its patented ultra-fast (1 ... to protect hospital patients and medical professionals from ... It enables effective, frequent and instantaneous hygiene practice ...
Cached Biology Technology:2008 a Record Year for Gerresheimer 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 3Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 4Germgard's Ultra-Fast Hand Hygiene Solution Protects Against Deadly MRSA, C difficile, and Influenza Virus 2
(Date:7/9/2015)... DUBLIN , July 07, 2015 ... has announced the addition of the "Biometrics ... and Forecasts 2015-2020" report to their offering. ... a major contributor to this growth and the ... US$5.5 billion in revenue for companies involved in ...
(Date:7/9/2015)... Calif. , July 9, 2015 /PRNewswire/ ... leading developer of human interface solutions, today ... the industry,s first fully hardware encapsulated fingerprint ... secure authentication technology is literally off the ... and biometric matching within the fingerprint sensor ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... today announced BD & Guidepoint Mentor, ... free access to Guidepoint,s expert network services. ... developing cutting-edge technologies to improve healthcare delivery and outcomes ... manager, each start-up entrepreneur will be able to directly ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... marks progress in understanding the basis of coral reef ... rare batfish, Platax pinnatus, in promoting the return to ... The findings bring to light a previously unrecognized role ... a significant player in reef recovery after overfishing. In ...
... single-celled organisms living in water, the force is always ... which consistently swims harder going up than going down, ... and James Valles of Brown University have worked out ... see how the creatures respond. , The researchers placed ...
... water pathogens may get a lot easier and cheaper thanks ... his team. , Syed Hashsham, an associate professor in ... for Microbial Ecology, is developing a portable, hand-held device capable ... water and food. , "This device will give ...
Cached Biology News:Fish species plays surprise role in aiding coral reef recovery 2Paramecia adapt their swimming to changing gravitational force 2Professors to develop hand-held pathogen testing device 2
Self Closing Forceps...
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... micro-bore tubes to 1 outflow Single-cell and ... Rapid (several millisecond) solution change Very small ... Solid construction 360, 250 and 100 ... mounting on any micromanipulator Available in 4, ...
... High Five cells (BTI-TN-5B1-4) derived from ... been shown to be capable of ... recombinant proteins compared to other insect ... following features:- -Rapid doubling time as adherent ...
Biology Products: